CLINICAL RESEARCH: CARDIAC IMAGING
Long-Term Prognostic Value of 13N-Ammonia Myocardial Perfusion Positron Emission TomographyAdded Value of Coronary Flow Reserve
Bernhard A. Herzog, MD*,
Lars Husmann, MD*,
Ines Valenta, MD*,
Oliver Gaemperli, MD*,
Patrick T. Siegrist, MD*,
Fabian M. Tay, MD*,
Nina Burkhard, MD*,
Christophe A. Wyss, MD* and
Philipp A. Kaufmann, MD*, ,*
* Cardiac Imaging Section, University Hospital Zurich, Zurich, Switzerland
Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland
Manuscript received October 7, 2008;
revised manuscript received January 30, 2009,
accepted February 17, 2009.
* Reprint requests and correspondence: Dr. Philipp A. Kaufmann, Cardiac Imaging, University Hospital Zurich, Ramistrasse 100, CH-8091 Zurich, Switzerland (Email: pak{at}usz.ch).
Objectives: The goal of this study was to assess the predictive value of myocardial perfusion imaging with 13N-ammonia positron emission tomography (PET) and coronary flow reserve (CFR) on long-term prognosis in patients with suspected myocardial ischemia.
Background: No prognostic data exist on the predictive value of CFR and 13N-ammonia PET.
Methods: Perfusion and CFR were assessed in 256 patients using 13N-ammonia PET, and follow-up was obtained in 245 (96%) patients. Sixteen early revascularized patients were excluded and 229 were assigned to normal versus abnormal perfusion or normal versus abnormal CFR (<2.0). Major adverse cardiac events (MACE) (cardiac death, nonfatal myocardial infarction, late revascularization, or hospitalization for cardiac reasons) were assessed using the Kaplan-Meier method. Cox proportional hazard regression was used to identify independent predictors for cardiac events.
Results: During follow-up (5.4 ± 2.2 years), 78 patients had at least 1 cardiac event, including 29 cardiac deaths. Abnormal perfusion (n = 126) was associated with a higher incidence of MACE (p < 0.001) and cardiac death (p < 0.05). In patients with normal perfusion, abnormal CFR was independently associated with a higher annual event rate over 3 years compared with normal CFR for MACE (1.4% vs. 6.3%; p < 0.05) and cardiac death (0.5% vs. 3.1%; p < 0.05). In abnormal perfusion, CFR remained predictive throughout the 10-year follow-up (p < 0.001).
Conclusions: Perfusion findings in 13N-ammonia PET and CFR are strong outcome predictors. CFR allows further risk stratification, suggesting a "warranty" period of 3 years if normal CFR is associated with normal perfusion. Conversely, in patients with abnormal perfusion, an impaired CFR has added value for predicting adverse outcomes.
Key Words: coronary flow reserve positron emission tomography 13N-ammonia myocardial perfusion imaging outcome
|
Abbreviations and Acronyms
| | CABG = coronary artery bypass grafting | | CAD = coronary artery disease | | CFR = coronary flow reserve | | MACE = major adverse cardiac advents | | MBF = myocardial blood flow | | MPI = myocardial perfusion imaging | | PCI = percutaneous coronary intervention | | PET = perfusion emission tomography | | SPECT = single-photon emission computerized tomography | | SSS = summed stress score |
|
Related Articles
-
Quantification of Myocardial Flow Reserve Using Positron Emission Imaging: The Journey to Clinical Use
- Rob S.B. Beanlands, Maria Cecilia Ziadi, and Kathryn Williams
J. Am. Coll. Cardiol. 2009 54: 157-159.
[Full Text]
[PDF]
-
Inside This Issue
J. Am. Coll. Cardiol. 2009 54: A24.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Bourque and G. A. Beller
Stress Myocardial Perfusion Imaging for Assessing Prognosis: An Update
J. Am. Coll. Cardiol. Img.,
December 1, 2011;
4(12):
1305 - 1319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. L. Murthy, M. Naya, C. R. Foster, J. Hainer, M. Gaber, G. Di Carli, R. Blankstein, S. Dorbala, A. Sitek, M. J. Pencina, et al.
Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve
Circulation,
November 15, 2011;
124(20):
2215 - 2224.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Di Carli and V. L. Murthy
Cardiac PET/CT for the Evaluation of Known or Suspected Coronary Artery Disease
RadioGraphics,
September 1, 2011;
31(5):
1239 - 1254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Ziadi, R. A. deKemp, K. A. Williams, A. Guo, B. J. W. Chow, J. M. Renaud, T. D. Ruddy, N. Sarveswaran, R. E. Tee, and R. S. B. Beanlands
Impaired Myocardial Flow Reserve on Rubidium-82 Positron Emission Tomography Imaging Predicts Adverse Outcomes in Patients Assessed for Myocardial Ischemia
J. Am. Coll. Cardiol.,
August 9, 2011;
58(7):
740 - 748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. M. Bengel
Leaving Relativity Behind: Quantitative Clinical Perfusion Imaging
J. Am. Coll. Cardiol.,
August 9, 2011;
58(7):
749 - 751.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Tamarappoo and R. Hachamovitch
Myocardial Perfusion Imaging Versus CT Coronary Angiography: When to Use Which?
J. Nucl. Med.,
July 1, 2011;
52(7):
1079 - 1086.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Quercioli, Z. Pataky, G. Vincenti, V. Makoundou, V. Di Marzo, F. Montecucco, S. Carballo, A. Thomas, C. Staub, S. Steffens, et al.
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity
Eur. Heart J.,
June 1, 2011;
32(11):
1369 - 1378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. J. A. Slart, C. J. Zeebregts, H. L. Hillege, J. de Sutter, R. A. J. O. Dierckx, D. J. van Veldhuisen, F. Zijlstra, and R. A. Tio
Myocardial Perfusion Reserve After a PET-Driven Revascularization Procedure: A Strong Prognostic Factor
J. Nucl. Med.,
June 1, 2011;
52(6):
873 - 879.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fukushima, M. S. Javadi, T. Higuchi, R. Lautamaki, J. Merrill, S. G. Nekolla, and F. M. Bengel
Prediction of Short-Term Cardiovascular Events Using Quantification of Global Myocardial Flow Reserve in Patients Referred for Clinical 82Rb PET Perfusion Imaging
J. Nucl. Med.,
May 1, 2011;
52(5):
726 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. Sherif, S. G. Nekolla, A. Saraste, S. Reder, M. Yu, S. Robinson, and M. Schwaiger
Simplified Quantification of Myocardial Flow Reserve with flurpiridaz F 18: Validation with Microspheres in a Pig Model
J. Nucl. Med.,
April 1, 2011;
52(4):
617 - 624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Vaccarino, D. Khan, J. Votaw, T. Faber, E. Veledar, D. P. Jones, J. Goldberg, P. Raggi, A. A. Quyyumi, and J. D. Bremner
Inflammation is Related to Coronary Flow Reserve Detected by Positron Emission Tomography in Asymptomatic Male Twins
J. Am. Coll. Cardiol.,
March 15, 2011;
57(11):
1271 - 1279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Gewirtz
Cardiac PET: A Versatile, Quantitative Measurement Tool for Heart Failure Management
J. Am. Coll. Cardiol. Img.,
March 1, 2011;
4(3):
292 - 302.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Anantharam, R. Janardhanan, S. Hayat, M. Hickman, N. Chahal, P. Bassett, and R. Senior
Coronary flow reserve assessed by myocardial contrast echocardiography predicts mortality in patients with heart failure
Eur Heart J Cardiovasc Imaging,
January 1, 2011;
12(1):
69 - 75.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Ghosh, O. E. Rimoldi, R. S. B. Beanlands, and P. G. Camici
Assessment of myocardial ischaemia and viability: role of positron emission tomography
Eur. Heart J.,
December 2, 2010;
31(24):
2984 - 2995.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. G. Camici
Advances in SPECT and PET for the management of heart failure
Heart,
December 1, 2010;
96(23):
1932 - 1937.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Alexanderson, J. M. Ochoa, R. Calleja, J. G. Juarez-Rojas, J. O. Prior, R. Jacome, E. Romero, A. Meave, and C. Posadas-Romero
Endothelial Dysfunction in Systemic Lupus Erythematosus: Evaluation with 13N-Ammonia PET
J. Nucl. Med.,
December 1, 2010;
51(12):
1927 - 1931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Achenbach, C. M. Kramer, W. A. Zoghbi, and V. Dilsizian
The Year in Coronary Artery Disease
J. Am. Coll. Cardiol. Img.,
October 1, 2010;
3(10):
1065 - 1077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kajander, E. Joutsiniemi, M. Saraste, M. Pietila, H. Ukkonen, A. Saraste, H. T. Sipila, M. Teras, M. Maki, J. Airaksinen, et al.
Cardiac Positron Emission Tomography/Computed Tomography Imaging Accurately Detects Anatomically and Functionally Significant Coronary Artery Disease
Circulation,
August 10, 2010;
122(6):
603 - 613.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Gaemperli, R. Liga, N. Spyrou, S. D. Rosen, R. Foale, J. S. Kooner, O. E. Rimoldi, and P. G. Camici
Myocardial {beta}-adrenoceptor down-regulation early after infarction is associated with long-term incidence of congestive heart failure
Eur. Heart J.,
July 2, 2010;
31(14):
1722 - 1729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Schindler, H. R. Schelbert, A. Quercioli, and V. Dilsizian
Cardiac PET Imaging for the Detection and Monitoring of Coronary Artery Disease and Microvascular Health
J. Am. Coll. Cardiol. Img.,
June 1, 2010;
3(6):
623 - 640.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. W. Wu, Y. H. Chen, S. S. Wang, H. Y. Jui, R. F. Yen, K. Y. Tzen, M. F. Chen, and C. M. Lee
PET Assessment of Myocardial Perfusion Reserve Inversely Correlates with Intravascular Ultrasound Findings in Angiographically Normal Cardiac Transplant Recipients
J. Nucl. Med.,
June 1, 2010;
51(6):
906 - 912.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Lubberink, H. J. Harms, R. Halbmeijer, S. de Haan, P. Knaapen, and A. A. Lammertsma
Low-Dose Quantitative Myocardial Blood Flow Imaging Using 15O-Water and PET Without Attenuation Correction
J. Nucl. Med.,
April 1, 2010;
51(4):
575 - 580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, G. K. Feld, B. H. Greenberg, J. Hall, M. Hlatky, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, et al.
Highlights of the Year in JACC 2009
J. Am. Coll. Cardiol.,
January 26, 2010;
55(4):
380 - 407.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S.B. Beanlands, M. C. Ziadi, and K. Williams
Quantification of Myocardial Flow Reserve Using Positron Emission Imaging: The Journey to Clinical Use
J. Am. Coll. Cardiol.,
July 7, 2009;
54(2):
157 - 159.
[Full Text]
[PDF]
|
 |
|
|